CD8A and breast cancer: No predictive effect was demonstrated with sTILs assessed on H&E or by CD8 IHC for DFS or distant-DFS for the prespecified subgroup analyses comprising luminal A versus non-luminal A breast cancers, the latter of which have been demonstrated to be more immunogenic14,22.